174 related articles for article (PubMed ID: 38512959)
1. Retinoid orphan receptor gamma t (rorγt) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis.
Torres-Huerta A; Ruley-Haase K; Reed T; Boger-May A; Rubadeux D; Mayer L; Rajashekara AM; Hiller M; Frech M; Roncagli C; Pedersen C; Camacho MC; Hollmer L; English L; Kane G; Boone DL
PLoS One; 2024; 19(3):e0300892. PubMed ID: 38512959
[TBL] [Abstract][Full Text] [Related]
2. The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis.
Overstreet AM; LaTorre DL; Abernathy-Close L; Murphy SF; Rhee L; Boger AM; Adlaka KR; Iverson AM; Bakke DS; Weber CR; Boone DL
Mucosal Immunol; 2018 Sep; 11(5):1454-1465. PubMed ID: 29988117
[TBL] [Abstract][Full Text] [Related]
3. Altered microbial biogeography in an innate model of colitis.
Boger-May A; Reed T; LaTorre D; Ruley-Haase K; Hoffman H; English L; Roncagli C; Overstreet AM; Boone D
Gut Microbes; 2022; 14(1):2123677. PubMed ID: 36162004
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
Qiu J; Zhou L
Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
[TBL] [Abstract][Full Text] [Related]
5. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.
Klose CS; Kiss EA; Schwierzeck V; Ebert K; Hoyler T; d'Hargues Y; Göppert N; Croxford AL; Waisman A; Tanriver Y; Diefenbach A
Nature; 2013 Feb; 494(7436):261-5. PubMed ID: 23334414
[TBL] [Abstract][Full Text] [Related]
6. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
7. T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells.
Schroeder JH; Meissl K; Hromadová D; Lo JW; Neves JF; Howard JK; Helmby H; Powell N; Strobl B; Lord GM
Front Immunol; 2020; 11():623324. PubMed ID: 33603753
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
Mizuno S; Mikami Y; Kamada N; Handa T; Hayashi A; Sato T; Matsuoka K; Matano M; Ohta Y; Sugita A; Koganei K; Sahara R; Takazoe M; Hisamatsu T; Kanai T
Inflamm Bowel Dis; 2014 Aug; 20(8):1426-34. PubMed ID: 24991784
[TBL] [Abstract][Full Text] [Related]
9. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
10. A distinct human cell type expressing MHCII and RORγt with dual characteristics of dendritic cells and type 3 innate lymphoid cells.
Ulezko Antonova A; Lonardi S; Monti M; Missale F; Fan C; Coates ML; Bugatti M; Jaeger N; Fernandes Rodrigues P; Brioschi S; Trsan T; Fachi JL; Nguyen KM; Nunley RM; Moratto D; Zini S; Kong L; Deguine J; Peeples ME; Xavier RJ; Clatworthy MR; Wang T; Cella M; Vermi W; Colonna M
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2318710120. PubMed ID: 38109523
[TBL] [Abstract][Full Text] [Related]
11. Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation.
Bhatt B; Zeng P; Zhu H; Sivaprakasam S; Li S; Xiao H; Dong L; Shiao P; Kolhe R; Patel N; Li H; Levy-Bercowski D; Ganapathy V; Singh N
J Immunol; 2018 Apr; 200(8):2905-2914. PubMed ID: 29514953
[TBL] [Abstract][Full Text] [Related]
12. ILC3 function as a double-edged sword in inflammatory bowel diseases.
Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
[TBL] [Abstract][Full Text] [Related]
13. Thiostrepton alleviates experimental colitis by promoting RORγt ubiquitination and modulating dysbiosis.
Luo Y; Liu C; Luo Y; Zhang X; Li J; Hu C; Yang S
Cell Mol Immunol; 2023 Nov; 20(11):1352-1366. PubMed ID: 37752225
[TBL] [Abstract][Full Text] [Related]
14. IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis.
Valle-Noguera A; Sancho-Temiño L; Castillo-González R; Villa-Gómez C; Gomez-Sánchez MJ; Ochoa-Ramos A; Yagüe-Fernández P; Soler Palacios B; Zorita V; Raposo-Ponce B; González-Granado JM; Aragonés J; Cruz-Adalia A
Cell Rep; 2023 Dec; 42(12):113508. PubMed ID: 38019650
[TBL] [Abstract][Full Text] [Related]
15. IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis.
Matsumoto A; Kanai T; Mikami Y; Chu PS; Nakamoto N; Ebinuma H; Saito H; Sato T; Yagita H; Hibi T
PLoS One; 2013; 8(4):e62853. PubMed ID: 23626860
[TBL] [Abstract][Full Text] [Related]
16. Gata3 drives development of RORγt+ group 3 innate lymphoid cells.
Serafini N; Klein Wolterink RG; Satoh-Takayama N; Xu W; Vosshenrich CA; Hendriks RW; Di Santo JP
J Exp Med; 2014 Feb; 211(2):199-208. PubMed ID: 24419270
[TBL] [Abstract][Full Text] [Related]
17. Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3.
Huang S; Wang X; Xie X; Su Y; Pan Z; Li Y; Liang J; Zhang M; Pan S; Xu B; Li L; Chen J; Luo X; Zhou L
J Ethnopharmacol; 2022 Dec; 299():115652. PubMed ID: 36038092
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin pre-treatment impairs tissue healing in experimental colitis: Importance of innate lymphoid cells.
Zhao D; Cai C; Zheng Q; Jin S; Song D; Shen J; Ran Z
Biochem Biophys Res Commun; 2017 Jan; 483(1):237-244. PubMed ID: 28034757
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated balance of retinoid-related orphan receptor γt-dependent innate lymphoid cells is involved in the pathogenesis of chronic DSS-induced colitis.
Kimura K; Kanai T; Hayashi A; Mikami Y; Sujino T; Mizuno S; Handa T; Matsuoka K; Hisamatsu T; Sato T; Hibi T
Biochem Biophys Res Commun; 2012 Nov; 427(4):694-700. PubMed ID: 23022186
[TBL] [Abstract][Full Text] [Related]
20.
Zhang W; Zhou Q; Liu H; Xu J; Huang R; Shen B; Guo Y; Ai X; Xu J; Zhao X; Liu Y; Wang Y; Zhi F
Front Immunol; 2023; 14():1156762. PubMed ID: 37114045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
